Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report

Hairong Wang,Yang Wan,Yun Yang,Hao Li,Liangwei Mao,Shuyang Gao,Jingjing Xu,Jing Wang
DOI: https://doi.org/10.1186/s12881-019-0850-7
2019-07-25
BMC Medical Genetics
Abstract:<h3 class="Heading">Background</h3><p class="Para">Oculocutaneous albinism (OCA) is a group of rare genetically heterogeneous disorders. The present study aimed to identify the genetic cause of a Chinese Han family with non-syndromic oculocutaneous albinism (OCA).</p><h3 class="Heading">Case presentation</h3><p class="Para">Here, we report an 11-month-old male proband from a Chinese Han non-consanguineous family, who presented with milky skin, yellow white hair, nystagmus, astigmatism, and hypermetropia. We performed the targeted next-generation sequencing (NGS) on the proband and identified two novel compound heterozygous variants (c.1865 T &gt; C (p.Leu622Pro) and exons 17–21 deletion) in <em class="EmphasisTypeItalic">OCA2</em> gene associated with OCA type 2 (OCA2, OMIM 203200). Meanwhile, a previously reported heterozygous mutation (c.4805G &gt; A) in <em class="EmphasisTypeItalic">MYO7</em> gene related with Usher syndrome type 1B was found. The online tools SIFT, PolyPhen-2, and Mutation Taster predicted variant c.1865 T &gt; C was probably damaging. The residue p.Leu622 was in a highly conserved region among species by CLUSTALW. Three-dimensional homology model with I-TASSER indicated that p.Leu622Pro variant disturbed the formation of the α-helix, resulting in a random coil structure. The gross deletion (exons 17–21) in <em class="EmphasisTypeItalic">OCA2</em> gene has was not been reported previously. These two novel variants in <em class="EmphasisTypeItalic">OCA2</em> gene were inherited from each parent respectively, after verification by Sanger sequencing and quantitative PCR (qPCR) in the family.</p><h3 class="Heading">Conclusions</h3><p class="Para">This study indicates the two novel compound heterozygous mutations in <em class="EmphasisTypeItalic">OCA2</em> gene may be responsible for clinical manifestations of OCA2. It expands the mutation spectrum of <em class="EmphasisTypeItalic">OCA2</em> gene and is helpful to screen for large deletions with targeted NGS protocol in monogenic disease. It also assists the genetic counselling, carrier screening and personalized healthcare of the disease.</p>
genetics & heredity
What problem does this paper attempt to address?